APGE Exercise Disclosure
Fairmount Funds Management Llc · SEC Form 4 · Filed Aug 11, 2026
Exercise
Calculated transaction value
$0
Fairmount Funds Management Llc Director
APGE
Apogee Therapeutics
APGE
Transaction date
Aug 7, 2026
Public filing date
Aug 11, 2026
Filing lag
Filed 4 days later
APGE daily price context
Close on/before transaction
$134.84
Aug 7, 2026
Close before public filing
$134.65
Aug 10, 2026
Return since public filing
+0.31%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 10,370 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-094087
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$995.97K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Apogee Therapeutics, Inc. APGE | Exercise | Aug 7, 2026 | $541.25K |
| Apogee Therapeutics, Inc. APGE | Exercise | Aug 7, 2026 | $454.72K |
| Apogee Therapeutics, Inc. APGE | Exercise | Aug 7, 2026 | $0 |
| Apogee Therapeutics, Inc. APGE Current | Exercise | Aug 7, 2026 | $0 |